Home  |  Contact Us  |  Site Map
| MENU |

Treatment / Staging of NMSCs

Reigneau M, Robert C, Routier E, Mamelle G, Moya-Plana A, Tomasic G, et al. Efficacy of neoadjuvant cetuximab alone or with platinum salt and fluorouracil for the treatment of unresectable locally advanced cutaneous squamous cell carcinomas. Br J Dermatol. 2015 Feb 21.

Allen JE, Stolle LB. Utility of sentinel node biopsy in patients with high-risk cutaneous squamous cell carcinoma. Eur J Surg Oncol. 2014 Nov 5. 

Krediet JT, Beyer M, Lenz K, Ulrich C, Lange-Asschenfeldt B, Stockfleth E, et al. Sentinel lymph node and risk factors for predicting metastasis in cutaneous squamous cell carcinoma. Br J Dermatol. 2014 Oct 31. 

Chu MB, Slutsky JB, Dhandha MM, Beal BT, Armbrecht ES, Walker RJ, et al. Evaluation of the definitions of “high-risk” cutaneous squamous cell carcinoma using the american joint committee on cancer staging criteria and national comprehensive cancer network guidelines. J Skin Cancer. 2014;2014:154340

Samstein RM, Ho AL, Lee NY, Barker CA. Locally advanced and unresectable cutaneous squamous cell carcinoma: outcomes of concurrent cetuximab and radiotherapy. J Skin Cancer. 2014;2014:284582.

Foote MC, McGrath M, Guminski A, Hughes BGM, Meakin J, Thomson D, et al. Phase II study of single agent panitumumab in patients with incurable cutaneous squamous cell carcinoma. Ann Oncol. 2014 Aug 4.

Karia PS, Jambusaria-Pahlajani A, Harrington DP, Murphy GF, Qureshi AA, Schmults CD. Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women's Hospital Tumor Staging for Cutaneous Squamous Cell Carcinoma. Journal of Clinical Oncology. Journal of Clinical Oncology. 2013 Dec 23.

Schmitt AR, Brewer JD, Bordeaux JS, Baum CL. Staging for Cutaneous Squamous Cell Carcinoma as a Predictor of Sentinel Lymph Node Biopsy Results: Meta-analysis of American Joint Committee on Cancer Criteria and a Proposed Alternative System. JAMA Dermatol. 2013 Nov 13.

Jambusaria-Pahlajani A, Kanetsky PA, Karia PS, Hwang WT, Gelfand JM, Whalen FM, Elenitsas R, Xu X, Schmults CD. Evaluation of AJCC Tumor Staging for Cutaneous Squamous Cell Carcinoma and a Proposed Alternative Tumor Staging System. JAMA Dermatol. 2013 Jan 16:1-9. doi: 10.1001/jamadermatol.2013.2456.

Kalapurakal SJ, Malone J, Robbins KT, Buescher L, Godwin J, Rao K. Cetuximab in refractory skin cancer treatment. J Cancer. 2012;3:257-61. doi: 10.7150/jca.3491. Epub 2012 Jun 7. PubMed PMID: 22712026; PubMed Central PMCID: PMC3376776.

Morton CA, Szeimies RM, Sidoroff A, Braathen LR. European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications - actinic keratoses, Bowen's disease, basal cell carcinoma. J Eur Acad Dermatol Venereol. 2012 Nov 26. doi: 10.1111/jdv.12031. [Epub ahead of print] PubMed PMID: 23181594.

Sargen M, Wanat KA, Jambusaria A, Rosenbach M, Sobanko J, Miller CJ. Systemic toxicity from occlusive therapy with topical 5-fluorouracil: a case report and review of the literature. Dermatol Surg. 2012 Oct;38(10):1756-9. doi: 10.1111/j.1524-4725.2012.02511.x. Epub 2012 Jul 17. PubMed PMID: 22805044.

Wells JL 3rd, Shirai K. Systemic therapy for squamous cell carcinoma of the skin in organ transplant recipients. Am J Clin Oncol. 2012 Oct;35(5):498-503.Review. PubMed PMID: 21297431.

Guleng GE, Helsing P. Photodynamic therapy for basal cell carcinomas in organ-transplant recipients. Clin Exp Dermatol. 2012 Jun;37(4):367-9. doi: 10.1111/j.1365-2230.2011.04248.x. Epub 2012 Mar 15. PubMed PMID: 22420420.

Upjohn E, Bhore R, Taylor RS. Solid organ transplant recipients presenting for Mohs micrographic surgery: a retrospective case-control study. Dermatol Surg. 2012 Sep;38(9):1448-55. doi: 10.1111/j.1524-4725.2012.02432.x. Epub 2012 May 15. PubMed PMID: 22587392. 

Zecher D, Steiger J. Future trends in organ transplant recipients--important issues for dermatologists. Curr Probl Dermatol. 2012;43:71-80. doi: 10.1159/000335153. Epub 2012 Feb 17. Review. PubMed PMID: 22377921.

Singh MK, Brewer JD. Current approaches to skin cancer management in organ transplant recipients. Semin Cutan Med Surg. 2011 Mar;30(1):35-47. doi: 10.1016/j.sder.2011.02.003. Review. PubMed PMID: 21540019.

Greenberg JN, Zwald FO. Management of Skin Cancer in Solid-organ Transplant Recipients: A Multidisciplinary Approach. Dermatol Clin. 2011 Apr;29(2):231-41, ix. doi: 10.1016/j.det.2011.02.004. Review. PubMed PMID: 21421148.

Trakatelli M, Katsanos G, Ulrich C, Kalabalikis D, Sotiriadis D, Stockfleth E. Efforts to counteract locally the effects of systemic immunosupression: a review on the use of imiquimod, a topical immunostimulator in organ transplant recipients. Int J Immunopathol Pharmacol. 2010 Apr-Jun;23(2):387-96. Review. PubMed PMID: 20646334. 

Vadnerkar A, Nguyen MH, Mitsani D, Crespo M, Pilewski J, Toyoda Y, Bermudez Neubauer KE, Goldstein GD, Plumb SJ. Squamous cell carcinoma of the scalp in organ transplant recipients: exploring mechanisms for recurrence and treatment guidelines. Dermatol Surg. 2010 Feb;36(2):185-93. doi: 10.1111/j.1524-4725.2009.01422.x. Epub 2009 Dec 21. PubMed PMID: 20039923. 

Ng J, Chong A, Foley P. Destructive management of skin cancers in organ transplant recipients. Cancer Treat Res. 2009;146:447-60. doi: 10.1007/978-0-387-78574-5_37. Review. PubMed PMID: 19415224.

Randle HW. Surgical intervention for skin cancer in organ transplant recipients. Cancer Treat Res. 2009;146:433-8. doi: 10.1007/978-0-387-78574-5_35. Review. PubMed PMID: 19415222. 

Kovach BT, Stasko T. Use of topical immunomodulators in organ transplant recipients. Dermatol Ther. 2005 Jan-Feb;18(1):19-27. Review. PubMed PMID: 15842609.

Martinez JC, Otley CC, Okuno SH, Foote RL, Kasperbauer JL. Chemotherapy in the management of advanced cutaneous squamous cell carcinoma in organ transplant recipients: theoretical and practical considerations. Dermatol Surg. 2004 Apr;30(4 Pt 2):679-86. Review. PubMed PMID: 15061855.

Carucci JA, Martinez JC, Zeitouni NC, Christenson L, Coldiron B, Zweibel S, Otley CC. In-transit metastasis from primary cutaneous squamous cell carcinoma in organ transplant recipients and nonimmunosuppressed patients: clinical characteristics, management, and outcome in a series of 21 patients. Dermatol Surg. 2004 Apr;30(4 Pt 2):651-5. PubMed PMID: 15061850.

Carucci JA. Cutaneous oncology in organ transplant recipients: meeting the challenge of squamous cell carcinoma. J Invest Dermatol. 2004 Nov;123(5):809-16. Review. PubMed PMID: 15482465.

Carucci JA. Squamous cell carcinoma in organ transplant recipients: approach to management. Skin Therapy Lett. 2004 Apr;9(4):5-7. Review. PubMed PMID: 15146264.

Clayton AS, Stasko T. Treatment of nonmelanoma skin cancer in organ transplant recipients: review of responses to a survey. J Am Acad Dermatol. 2003 Sep;49(3):413-6. Review. PubMed PMID: 12963903.

Carucci JA. Management of squamous cell carcinoma in organ transplant recipients. Semin Cutan Med Surg. 2003 Sep;22(3):177-86. Review. PubMed PMID: 14649585.

Grabski WJ, Salasche SJ, Mulvaney MJ. Razor-blade surgery. J Dermatol Surg Oncol. 1990 Dec;16(12):1121-6. PubMed PMID: 2262620.



Updated on Friday, January 11th, 2013

ITSCC

Your tax-deductible donation supports the education and research of physicians and scientists committed to improving the quality of life of organ transplant recipients. If you are unable to donate online or require other information to make a gift through a trust or other source, email info@itscc.org for additional assistance. ITSCC's federal tax ID is 43-1964114.

Support ITSCC video

ITSCC is a nonprofit 501(c)(3) organization, and has received support through unrestricted educational grants from pharmaceutical companies and donations of time and funds from physicians, researchers, transplant patients and their families.